from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1090/celA2b

LFCtreatmentdescriptionclass of inhibitor

-0.583

Amikacinug/mL Amikacintranslation

0.161

Cap5-10ug/mL Capreomycintranslation

0.170

Rox10-50 ug/mL Roxithromycintranslation

-0.587

SM2-5 ug/mL Streptomycintranslation

-0.063

Tet5-10 ug/mL Tetracyclinetranslation

0.160

Rif0.2-5ug/mL Rifampicintranscription

0.238

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.494

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.410

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.081

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.024

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.275

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.192

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.551

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.111

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.384

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.489

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.215

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.618

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.016

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.790

KCN5-20 ug/mL Potassium cyaniderespiration

-0.401

NaN30.2-2 mM Sodium aziderespiration

-1.477

Nigericin50 uM Nigericinrespiration

0.693

TRC10-150 ug/mL Triclosanrespiration

1.917

TRZ10-25 ug/mL Thioridazinerespiration

-0.425

Valinomycin0.5-10 uM Valinomycinrespiration

-1.817

ZnSO42 mM ZnSO4respiration

-0.361

menadione6-10 ug/mL Menadionerespiration

0.082

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.825

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.660

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.198

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.536

NRP_1Non-replicating persistence stage 1dosRassociated

-0.798

Amp0.2mg/mL AmpicillincellWall

-0.325

Cephalexin20-100 ug/mL CephalexincellWall

-0.283

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.104

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.871

EMB10-20 ug/mL EthambutolcellWall

-0.850

Eta12-40 ug/mL EthionamidecellWall

-0.974

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.262

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.297

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.831

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.081

BZA0.12 mg/mL BenzamidearomaticAmides

0.436

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.270

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.351

H2O24 mM hydrogen peroxideDNAdamaging

-0.009

Levo10 ug/mL LevofloxacinDNAdamaging

0.212

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.469

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.320

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.136

UVUV-irradiationDNAdamaging

1.602

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.031

Antimycin12.5-50 ug/mL Antimycin A?

-0.600

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.484

PA_110-50 ug/mL Antitubercular compound PA-1?

0.097

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.859

PA8240.2-2 ug/mL PA-824?

0.149

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.255

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.447

Verapamil50 uM Verapamil?

-0.224

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.718

methoxatin10-20 ug/mL Methoxatin?